ECEESPE2025 ePoster Presentations Adrenal and Cardiovascular Endocrinology (170 abstracts)
Impact of cushing’s syndrome treatment on glycemic control and diabetic complications
Baltagi Myriam 1 , Ibtissem Ben Nacef 1 , Sawsen Essayeh 1 , Sabrine Mekni 1 , Rihab Laamouri 1 , Khiari Karima 1 & Rojbi Imen 1
1Hospital of Charles Nicolle, Tunis, Tunisia
JOINT2276
Introduction: Cushing’s syndrome (CS) is associated with a high risk of developing diabetes and related complications. This study assesses the impact of CS treatment on glycemic control and the development of diabetic complications.
Methods: A cohort of 22 CS patients was followed from diagnosis through treatment. Glycemic control (fasting blood glucose, HbA1c) was measured before and after treatment, and diabetic complications (retinopathy, neuropathy, nephropathy) were assessed.
Results: Post-treatment, significant improvements in fasting blood glucose (mean decrease of 23%) and HbA1c (mean decrease of 0.9%) were observed. Diabetic complications were present in 36% of patients at diagnosis but reduced to 15% post-treatment. These improvements were associated with a significant reduction in cortisol levels.
Discussion: The findings suggest that successful treatment of CS not only improves glycemic control but also reduces the risk of developing diabetic complications. The relationship between cortisol levels and glycemic control underscores the role of cortisol in the pathogenesis of diabetes in CS patients.
Conclusion: Treatment of Cushing’s syndrome significantly improves both glycemic control and diabetic complications. Early and effective management of cortisol excess is essential to prevent or mitigate these complications.
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more